Accordingly, p38MAPK is progressively activated in neurons affected by AD [122] as well as in APP transgenic mice brains [121], and neuronal p38αMAPK mediates synaptic and cognitive dysfunction in a murine model of AD by controlling amyloid-β (Aβ) production [120]. The gene discussed is APP; the disease is Alzheimer disease.